Hospitalization for respiratory syncytial virus in the paediatric population in Spain

D Vicente1, M Montes, G Cilla

  • 1Servicio de Microbiología, Hospital Donostia, Paseo Dr. Beguiristain s/n 20014 San Sebastián, Spain.

Insights

Community-acquired respiratory syncytial virus (RSV) infection frequently hospitalizes young children in Spain. Infants under one year old are most affected, highlighting the need for RSV prevention strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired respiratory syncytial virus (RSV) is a significant pathogen in pediatric populations.
  • Understanding the incidence of RSV-related hospitalizations is crucial for public health planning.

Purpose of the Study:

  • To determine the incidence of hospitalization for laboratory-confirmed RSV infection in children under five years old in southern Europe.
  • To identify risk factors and demographic trends associated with RSV hospitalizations.

Main Methods:

  • Population-based retrospective study analyzing data from July 1996 to June 2000.
  • Inclusion of 15,700 children under five years old served by a single hospital.
  • Laboratory confirmation of RSV in nasopharyngeal aspirates from children with acute respiratory infections.

Main Results:

  • 390 RSV hospitalizations were detected; 83.3% of affected children were under one year old.
  • Annual hospitalization rates were 37/1000 for infants under 6 months and 25/1000 for those under 1 year.
  • 2.5% of infants under one year and 5% under three months were hospitalized; 7% required ICU admission, mostly neonates.

Conclusions:

  • RSV infection is a frequent cause of hospitalization in young Spanish children, particularly those under one year.
  • The high incidence underscores the need for effective RSV prevention strategies, including vaccines.
  • RSV prevention should be a public health priority to reduce pediatric hospitalizations.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...